Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUNSHINE: Fidaxomicin vs Vancomycin in Pediatric CDAD
NCT02218372Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Jan 2015
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of fidaxomicin in Clostridioides difficile infection (CDI), sponsored by Astellas Pharma. Started Jan 2015; status: completed.
02
Drugs
fidaxomicin
03
Conditions
Clostridioides difficile infection (CDI)
Beyond the preview
Go deeper on NCT02218372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02218372.